Alerts will be sent to your verified email
Verify EmailVENMAX
|
Venmax Drugs&Pharma
|
Zenith Health Care
|
Desh Rakshak Aushdh
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
-46.46 % | 3.1 % | 4.74 % |
|
5yr average Equity Multiplier
|
0.08 | 1.38 | 1.73 |
|
5yr Average Asset Turnover Ratio
|
0.14 | 1.51 | 0.39 |
|
5yr Avg Net Profit Margin
|
-19.62 % | 1.44 % | 7.09 % |
|
Price to Book
|
2.1 | 2.52 | 1.47 |
|
P/E
|
53.56 | 0.0 | 28.96 |
|
5yr Avg Cash Conversion Cycle
|
288.55 Days | 46.26 Days | -280.35 Days |
|
Inventory Days
|
5.2 Days | 71.2 Days | 36.63 Days |
|
Days Receivable
|
430.69 Days | 75.61 Days | 363.29 Days |
|
Days Payable
|
141.12 Days | 64.53 Days | 408.55 Days |
|
5yr Average Interest Coverage Ratio
|
-260.56 | 35.13 | 2.89 |
|
5yr Avg ROCE
|
-47.43 % | 5.45 % | 6.6 % |
|
5yr Avg Operating Profit Margin
|
-65.91 % | 1.4 % | 19.52 % |
|
5 yr average Debt to Equity
|
-0.45 | 0.0 | 0.38 |
|
5yr CAGR Net Profit
|
-42.57 % | -30.76 % | 2.71 % |
|
5yr Average Return on Assets
|
199.45 % | 2.29 % | 2.74 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
23.13 % | 28.74 % | 50.07 % |
|
Share Pledged by Promoters
|
0.0 | 0.0 | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
0.0 | 0.0 | -14.21 % |
|
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 0.0 | 0.0 |
|
Venmax Drugs&Pharma
|
Zenith Health Care
|
Desh Rakshak Aushdh
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|